Microcannular Tumescent Liposuction in Advanced Lipedema and Dercum’s Disease

Microcannular Tumescent Liposuction in Advanced Lipedema and Dercum’s Disease

Wollina U, Goldman A, Heinig B; 2010

Synopsis: This study evaluated the outcome and risks of tumescence liposuction in patients with advanced lipedema or Dercum’s disease.

Abstract: AIM: We evaluated the outcome and risks of tumescence liposuction in patients with advanced lipedema or Dercum’s disease.

METHODS: Six patients treated at a single center during the years 2004 to 2008 have been included. All patients were female and obese (body mass index 34 to 41.9; mean 38.2+/-3.8) with an age range from 29 to 78 years (mean 55.7+/-20.5 years), five of them had co-morbidities.

RESULTS: The total amount of lipoaspirates varied between 1500 mL and 4800 mL. Pain could be reduced in all four patients with Dercum’s disease. Large adipose tissue removing implies a better the outcome for pain. Patient’s satisfaction was “high” or “very high” in 5 and “medium” in one. The most common adverse effect was met-hemoglobulinemia (N.=4).

CONCLUSION: Tumescence liposuction is a treatment option for lipedema and Dercum’s disease. With careful monitoring the procedure is safe even for patients in advanced stages, higher age and with co-morbidities.

APA Citation: Wollina, U., Goldman, A., & Heinig, B. (2010). Microcannular tumescent liposuction in advanced lipedema and Dercums disease. G Ital Dermatol Venereol, 145(2), 151-9.

AMA Citation: Wollina U, Goldman A, Heinig B. Microcannular tumescent liposuction in advanced lipedema and Dercums disease. G Ital Dermatol Venereol. 2010;145(2):151-9.